Back to top

Akari Therapeutics upgraded to Buy from Hold at Maxim

Maxim upgraded Akari Therapeutics (AKTX) to Buy from Hold with a $30 price target Published first on TheFly – the ultimate source for real-time, ma...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Akari Therapeutics PLC (AKTX)